"Immunohistochemistry" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Histochemical localization of immunoreactive substances using labeled antibodies as reagents.
| Descriptor ID |
D007150
|
| MeSH Number(s) |
E01.370.225.500.607.512 E01.370.225.750.551.512 E05.200.500.607.512 E05.200.750.551.512 E05.478.583 H01.158.100.656.234.512 H01.158.201.344.512 H01.158.201.486.512 H01.181.122.573.512 H01.181.122.605.512
|
| Concept/Terms |
Immunolabeling Techniques- Immunolabeling Techniques
- Immunolabeling Technique
- Technique, Immunolabeling
- Techniques, Immunolabeling
- Immunolabeling Technics
- Immunolabeling Technic
- Technic, Immunolabeling
- Technics, Immunolabeling
Immunogold Techniques- Immunogold Techniques
- Immunogold Technique
- Technique, Immunogold
- Techniques, Immunogold
- Immunogold Technics
- Immunogold Technic
- Technic, Immunogold
- Technics, Immunogold
Immunogold-Silver Techniques- Immunogold-Silver Techniques
- Immunogold Silver Techniques
- Immunogold-Silver Technique
- Technique, Immunogold-Silver
- Techniques, Immunogold-Silver
- Immunogold-Silver Technics
- Immunogold Silver Technics
- Immunogold-Silver Technic
- Technic, Immunogold-Silver
- Technics, Immunogold-Silver
|
Below are MeSH descriptors whose meaning is more general than "Immunohistochemistry".
Below are MeSH descriptors whose meaning is more specific than "Immunohistochemistry".
This graph shows the total number of publications written about "Immunohistochemistry" by people in this website by year, and whether "Immunohistochemistry" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 30 | 30 |
| 1997 | 2 | 36 | 38 |
| 1998 | 0 | 28 | 28 |
| 1999 | 0 | 36 | 36 |
| 2000 | 1 | 33 | 34 |
| 2001 | 0 | 48 | 48 |
| 2002 | 0 | 47 | 47 |
| 2003 | 0 | 55 | 55 |
| 2004 | 0 | 47 | 47 |
| 2005 | 0 | 68 | 68 |
| 2006 | 0 | 62 | 62 |
| 2007 | 0 | 56 | 56 |
| 2008 | 3 | 56 | 59 |
| 2009 | 0 | 69 | 69 |
| 2010 | 2 | 65 | 67 |
| 2011 | 2 | 49 | 51 |
| 2012 | 0 | 59 | 59 |
| 2013 | 1 | 55 | 56 |
| 2014 | 3 | 54 | 57 |
| 2015 | 2 | 43 | 45 |
| 2016 | 2 | 44 | 46 |
| 2017 | 4 | 39 | 43 |
| 2018 | 1 | 29 | 30 |
| 2019 | 4 | 28 | 32 |
| 2020 | 5 | 18 | 23 |
| 2021 | 1 | 22 | 23 |
| 2022 | 0 | 6 | 6 |
| 2023 | 1 | 4 | 5 |
| 2024 | 1 | 16 | 17 |
| 2025 | 3 | 2 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunohistochemistry" by people in Profiles.
-
Immunohistochemistry and Morphometric Analysis of Drosophila Larval Body Wall Neuromuscular Junction Preparations. Cold Spring Harb Protoc. 2025 Jul 01; 2025(7):pdb.prot108500.
-
Using the Proximity Ligation Assay to Visualize Colocalization of Proteins at the Drosophila Larval Neuromuscular Junction. Cold Spring Harb Protoc. 2025 Jul 01; 2025(7):pdb.prot108502.
-
Protocol to characterize longitudinal gut motility in mice using transit time, tissue harvest, and whole-mount immunostaining. STAR Protoc. 2025 Jun 20; 6(2):103761.
-
Novel Histologic Features in Ameloblastoma With RASQ61R Mutation. Am J Surg Pathol. 2025 May 01; 49(5):508-514.
-
Female Adnexal Tumor of Probable Wolffian Origin (FATWO): An Unusual Case With Development of Peritoneal Lesions After 3 Decades. Int J Gynecol Pathol. 2025 Sep 01; 44(5):453-456.
-
DEK :: AFF2 Fusion Sinonasal and Skull Base Nonkeratinizing Squamous Cell Carcinoma : A Clinical Outcome Study Compared With Conventional Sinonasal Squamous Cell Carcinoma. Am J Surg Pathol. 2025 Feb 01; 49(2):130-137.
-
Aggressive renal cell carcinoma with somatic BRCA2 mutation-an emerging entity? A case report with literature review. Virchows Arch. 2025 Aug; 487(2):471-476.
-
Nationwide survey on HER2 and PD-L1 testing practices in gastric cancer across Japan. Gastric Cancer. 2025 Mar; 28(2):294-300.
-
High tumor glucocorticoid receptor expression in early-stage, triple-negative breast cancer is associated with increased T-regulatory cell infiltration. Breast Cancer Res Treat. 2025 Feb; 209(3):563-572.
-
GATA3 Expression in Solid Vimentin-Negative Eosinophilic Renal Epithelial Tumors-A Comprehensive Study of 48 Tumors. Int J Surg Pathol. 2025 Jun; 33(4):820-827.